Literature DB >> 23788661

Modulation of reactivation of latent herpes simplex virus 1 in ganglionic organ cultures by p300/CBP and STAT3.

Te Du1, Guoying Zhou, Bernard Roizman.   

Abstract

A key property of herpes simplex viruses (HSVs) is their ability to establish latent infection in sensory or autonomic ganglia and to reactivate on physical, hormonal, or emotional stress. In latently infected ganglia, HSV expresses a long noncoding RNA and a set of microRNAs, but viral proteins are not expressed. The mechanism by which latent HSV reactivates is unknown. A key question is, what is the mechanism of reactivation in the absence of tegument proteins that enable gene expression in productive infection? Elsewhere we have reported the use of ganglionic organ cultures that enable rapid reactivation in medium containing antibody to NGF or delayed reactivation in medium containing NGF and EGF. We also reported that in the ganglionic organ cultures incubated in medium containing antibody to NGF, all viral genes are derepressed at once without requiring de novo protein synthesis within the time frame of a single replicative cycle. Here we report that latent HSV in ganglia immersed in medium containing NGF and EGF is reactivated by (i) broad spectrum as well as specific histone deacetylase 1 or histone deacetylase 4 inhibitors, (ii) activation of p300/CBP, and (iii) either STAT3 carrying the substitution of tyrosine 705 to phenylalanine or an inhibitor of STAT3. Conversely, reactivation of latent HSV was blocked by p300/CBP inhibitor in medium containing antibody to NGF. The results suggest that (i) STAT3 is required for the maintenance of the latent state and interference with its functions leads to reactivation and (ii) p300/CBP is essential for HSV reactivation.

Entities:  

Keywords:  latency-associated transcript; nerve growth factor

Mesh:

Substances:

Year:  2013        PMID: 23788661      PMCID: PMC3710862          DOI: 10.1073/pnas.1309906110

Source DB:  PubMed          Journal:  Proc Natl Acad Sci U S A        ISSN: 0027-8424            Impact factor:   11.205


  44 in total

1.  Real time analysis of STAT3 nucleocytoplasmic shuttling.

Authors:  Albert L Pranada; Silke Metz; Andreas Herrmann; Peter C Heinrich; Gerhard Müller-Newen
Journal:  J Biol Chem       Date:  2003-12-29       Impact factor: 5.157

Review 2.  The first 30 minutes in the life of a virus: unREST in the nucleus.

Authors:  Bernard Roizman; Haidong Gu; Gail Mandel
Journal:  Cell Cycle       Date:  2005-08-07       Impact factor: 4.534

Review 3.  Herpes simplex virus encephalitis: new infection or reactivation?

Authors:  Israel Steiner
Journal:  Curr Opin Neurol       Date:  2011-06       Impact factor: 5.710

4.  Constitutive activation of Stat3 signaling confers resistance to apoptosis in human U266 myeloma cells.

Authors:  R Catlett-Falcone; T H Landowski; M M Oshiro; J Turkson; A Levitzki; R Savino; G Ciliberto; L Moscinski; J L Fernández-Luna; G Nuñez; W S Dalton; R Jove
Journal:  Immunity       Date:  1999-01       Impact factor: 31.745

5.  Disruption of HDAC/CoREST/REST repressor by dnREST reduces genome silencing and increases virulence of herpes simplex virus.

Authors:  Te Du; Guoying Zhou; Shaniya Khan; Haidong Gu; Bernard Roizman
Journal:  Proc Natl Acad Sci U S A       Date:  2010-08-23       Impact factor: 11.205

6.  Histone deacetylase inhibitors induce reactivation of herpes simplex virus type 1 in a latency-associated transcript-independent manner in neuronal cells.

Authors:  Robert J Danaher; Robert J Jacob; Marion R Steiner; Will R Allen; James M Hill; Craig S Miller
Journal:  J Neurovirol       Date:  2005-07       Impact factor: 2.643

Review 7.  Therapeutic application of histone deacetylase inhibitors for central nervous system disorders.

Authors:  Aleksey G Kazantsev; Leslie M Thompson
Journal:  Nat Rev Drug Discov       Date:  2008-10       Impact factor: 84.694

8.  Specific histone tail modification and not DNA methylation is a determinant of herpes simplex virus type 1 latent gene expression.

Authors:  Nicole J Kubat; Robert K Tran; Peterjon McAnany; David C Bloom
Journal:  J Virol       Date:  2004-02       Impact factor: 5.103

9.  Inhibition of STAT3 signaling induces apoptosis and decreases survivin expression in primary effusion lymphoma.

Authors:  Yoshiyasu Aoki; Gerald M Feldman; Giovanna Tosato
Journal:  Blood       Date:  2002-10-03       Impact factor: 22.113

10.  An investigation of herpes simplex virus promoter activity compatible with latency establishment reveals VP16-independent activation of immediate-early promoters in sensory neurones.

Authors:  João T Proença; Heather M Coleman; Michael P Nicoll; Viv Connor; Christopher M Preston; Jane Arthur; Stacey Efstathiou
Journal:  J Gen Virol       Date:  2011-07-13       Impact factor: 3.891

View more
  32 in total

1.  Patterns of accumulation of miRNAs encoded by herpes simplex virus during productive infection, latency, and on reactivation.

Authors:  Te Du; Zhiyuan Han; Guoying Zhou; Grace Zhou; Bernard Roizman
Journal:  Proc Natl Acad Sci U S A       Date:  2014-12-22       Impact factor: 11.205

2.  Antagonizing the Glucocorticoid Receptor Impairs Explant-Induced Reactivation in Mice Latently Infected with Herpes Simplex Virus 1.

Authors:  Kelly S Harrison; Liqian Zhu; Prasanth Thunuguntla; Clinton Jones
Journal:  J Virol       Date:  2019-06-14       Impact factor: 5.103

3.  Pan-viral-microRNA screening identifies interferon inhibition as a common function of diverse viruses.

Authors:  Jennifer E Cox; Lydia V McClure; Andrei Goga; Christopher S Sullivan
Journal:  Proc Natl Acad Sci U S A       Date:  2015-01-26       Impact factor: 11.205

4.  Mutations Inactivating Herpes Simplex Virus 1 MicroRNA miR-H2 Do Not Detectably Increase ICP0 Gene Expression in Infected Cultured Cells or Mouse Trigeminal Ganglia.

Authors:  Dongli Pan; Jean M Pesola; Gang Li; Seamus McCarron; Donald M Coen
Journal:  J Virol       Date:  2017-01-03       Impact factor: 5.103

5.  Inhibition of H3K27me3-specific histone demethylases JMJD3 and UTX blocks reactivation of herpes simplex virus 1 in trigeminal ganglion neurons.

Authors:  Harald G P Messer; Derek Jacobs; Adit Dhummakupt; David C Bloom
Journal:  J Virol       Date:  2014-12-31       Impact factor: 5.103

6.  Varicella-Zoster Virus Activates CREB, and Inhibition of the pCREB-p300/CBP Interaction Inhibits Viral Replication In Vitro and Skin Pathogenesis In Vivo.

Authors:  Sylvie François; Nandini Sen; Bryan Mitton; Xiangshu Xiao; Kathleen M Sakamoto; Ann Arvin
Journal:  J Virol       Date:  2016-09-12       Impact factor: 5.103

7.  The stability of herpes simplex virus 1 ICP0 early after infection is defined by the RING finger and the UL13 protein kinase.

Authors:  Zhi Zhu; Te Du; Guoying Zhou; Bernard Roizman
Journal:  J Virol       Date:  2014-02-26       Impact factor: 5.103

8.  STAT3 Regulates Lytic Activation of Kaposi's Sarcoma-Associated Herpesvirus.

Authors:  Christine A King; Xiaofan Li; Arturo Barbachano-Guerrero; Sumita Bhaduri-McIntosh
Journal:  J Virol       Date:  2015-09-02       Impact factor: 5.103

9.  Signal transducer and activator of transcription 3 (Stat3) regulates host defense and protects mice against herpes simplex virus-1 (HSV-1) infection.

Authors:  Hung-Ching Hsia; Charles M Stopford; Zhigang Zhang; Blossom Damania; Albert S Baldwin
Journal:  J Leukoc Biol       Date:  2016-12-13       Impact factor: 4.962

10.  Role of activating transcription factor 3 in the synthesis of latency-associated transcript and maintenance of herpes simplex virus 1 in latent state in ganglia.

Authors:  Minfeng Shu; Te Du; Grace Zhou; Bernard Roizman
Journal:  Proc Natl Acad Sci U S A       Date:  2015-08-24       Impact factor: 11.205

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.